Trace’nTreat network trains young researchers in the battle against cancer

The European Commission has awarded over two million euros in funding to the Trace’nTreat project within the Marie Curie Initial Training Network (ITN) of the 7th Framework Programme. The coordination of the project will be the responsibility of the Radiation Science and Technology department of the TU Delft, the Netherlands. The aim of the network is to train young researchers in nuclear diagnostics and radionuclide therapy. The project duration is 4 years starting from the 1st of October 2012. During this period young researchers will be trained at different academic institutions and private companies, each with their own specific expertise, which will enable them to develop new, pioneering products and treatments all contributing to the fight against cancer.

High-quality multidisciplinary education programme

The Marie Curie Initial Training Network offers funding to train researchers, often in the framework of a Ph.D. research. The aim of the ITN Marie Curie program is to provide high-quality, multidisciplinary education programs to young, highly motivated researchers. The Trace’nTreat fellows will be trained in various disciplines, including nuclear imaging, targeted radionuclide therapy, soft matter, and nuclear-, polymer- and radiopharmaceutical chemistry with the goal of reducing the number of deaths caused by cancer. The program focuses on the entire health care cycle, from prevention to diagnostics and from treatment to monitoring.

Cooperation of leading European institutes

The Trace’nTreat network is a cooperation of a number of leading European institutes and industrial partners: Erasmus MC, MILabs, Johannes Gutenberg Universität Mainz, Ghent University, Centre National de la Recherche Scientifique – Institute Charles Sadron, IDB Holland, Urenco Nederland, Institute of Transuranium Elements and TU Delft. The variety of expertise within this network ensures the Ph.D. candidates will receive multidisciplinary training considerably improving their career perspectives in the health sector.

Network of professionals

In addition to training future professionals in multidisciplinary competencies in one of the most important areas of health care, the program aims to create a network of professionals from a range of different scientific backgrounds, who are committed to improve and develop nuclear molecular imaging and radionuclide therapy. A total of eight Ph.D. positions are available within this project.

For more information:

Dr. ir.  Antonia Denkova (project coordinator) – [email protected] – +31 (0)152784471

Share on social media

Beckman Institute welcomes new ultra-high-performance PET-CT scanner

Beckman Institute at the University of Illinois, Urbana-Champaign Improves Previous Imaging Functionality with Launch of ...
Read More →

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. ...
Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value ...
Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs ...
Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V ...
Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” ...
Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and ...
Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of ...
Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a ...
Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress ...
Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor ...
Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting ...
Read More →
Scroll to Top